NCT04196309View on ClinicalTrials.gov

Effect of LOW-molecular-weight Heparin in Reducing Radial Artery Occlusion Rate After Transradial Coronary Catheterization

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 25, 2017

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Arterial Occlusion
Interventions
DRUG

low molecular weight heparin

LMWH (tinzaparin) at body-weight-adjusted therapeutic dose (175 anti-Xa IU/kg subcutaneously once daily)

Trial Locations (1)

54636

1st Cardiology Department, University General Hospital AHEPA, Thessaloniki

All Listed Sponsors
lead

AHEPA University Hospital

OTHER

NCT04196309 - Effect of LOW-molecular-weight Heparin in Reducing Radial Artery Occlusion Rate After Transradial Coronary Catheterization | Biotech Hunter | Biotech Hunter